Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (30)
Xiao Chen, Zhu Tao, Yun Liang, Meng Ma, Dickson Adah, Wenting Ding, Lili Chen, Xiaofen Li, Linglin Dai, Songwe Fanuel, Siting Zhao, Wen Hu, Donghai Wu, Ziyuan Duan, Fang Zhou, Li Qin, Xiaoping Chen & Zhaoqing Yang. (2023) Plasmodium immunotherapy combined with gemcitabine has a synergistic inhibitory effect on tumor growth and metastasis in murine Lewis lung cancer models. Frontiers in Oncology 13.
Crossref
Crossref
Hafiza Padinharayil, Reema Rose Alappat, Liji Maria Joy, Kavya V. Anilkumar, Cornelia M. Wilson, Alex George, Abilash Valsala Gopalakrishnan, Harishkumar Madhyastha, Thiyagarajan Ramesh, Ezhaveni Sathiyamoorthi, Jintae Lee & Raja Ganesan. (2022) Advances in the Lung Cancer Immunotherapy Approaches. Vaccines 10:11, pages 1963.
Crossref
Crossref
Guiyuan Liu, Dehu Chen, Xiaojun Zhao, Xiaolan You, Chuanjiang Huang, Zhiyi Cheng, Xunan Mao & Haihua Zhou. (2022) Efficacy of DC-CIK Immunotherapy Combined with Chemotherapy on Locally Advanced Gastric Cancer. Journal of Oncology 2022, pages 1-6.
Crossref
Crossref
Yuejiao Huang, Shiyi Qin, Xinliang Gu, Ming Zheng, Qi Zhang, Yupeng Liu, Chun Cheng, Kaibin Huang, Chunlei Peng & Shaoqing Ju. (2022) Comprehensive Assessment of Serum hsa_circ_0070354 as a Novel Diagnostic and Predictive Biomarker in Non-small Cell Lung Cancer. Frontiers in Genetics 12.
Crossref
Crossref
Lin-Rui Ma, Jia-Xin Li, Ling Tang, Run-Ze Li, Jia-Shun Yang, Ao Sun, Elaine Leung & Pei-Yu Yan. (2021) Immune checkpoints and immunotherapy in non‑small cell lung cancer: Novel study progression, challenges and solutions (Review). Oncology Letters 22:5.
Crossref
Crossref
Wei Zhang, Lin Wei, Rong Luo, Hui Liu & Jing Chen. (2020) The value of microRNA-21 as a biomarker for the prognosis of lung cancer. Medicine 99:33, pages e21483.
Crossref
Crossref
Xiaoyou Li, Xia Zhao, Chenchen Li, Siwen Liu, Fei Yan, Yue Teng, Jifeng Feng & Dengshun Miao. (2019) Inhibitor of ghrelin receptor reverses gefitinib resistance in lung cancer. Human Cell 32:3, pages 360-366.
Crossref
Crossref
Li Zhang & Yanyan Pan. 2018. Lung Cancer - Strategies for Diagnosis and Treatment. Lung Cancer - Strategies for Diagnosis and Treatment.
Yang LiuYang Liu. 2018. Multifunctional Gold Nanostars for Cancer Theranostics. Multifunctional Gold Nanostars for Cancer Theranostics
55
63
.
Julie Jacobs, Vanessa Deschoolmeester, Christian Rolfo, Karen Zwaenepoel, Jolien Van den Bossche, Christophe Deben, Karen Silence, Hans de Haard, Christophe Hermans, Sylvie Rottey, Christel Vangestel, Filip Lardon, Evelien Smits & Patrick Pauwels. (2017) Preclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy. Oncotarget 8:43, pages 74058-74067.
Crossref
Crossref
Tanzhen Liu, Jingjing Wei, Chao Jiang, Chen Wang, Xiaoqin Zhang, Yan Du, Jianqiang Li & Hui Zhao. (2017) CHAF1A, the largest subunit of the chromatin assembly factor?1 complex, regulates the growth of H1299 human non‑small cell lung cancer cells by inducing G0/G1 cell cycle arrest. Experimental and Therapeutic Medicine.
Crossref
Crossref
Dong Zhang, Huimin Wang, Huijie He, Haiying Niu & Yu Li. (2017) Interferon induced transmembrane protein 3 regulates the growth and invasion of human lung adenocarcinoma. Thoracic Cancer 8:4, pages 337-343.
Crossref
Crossref
Qinxiang Guo, Yu Sun, Sifan Yu, Hua Bai, Jun Zhao, Minglei Zhuo & Jie Wang. (2017) Programmed cell death-ligand 1 (PD-L1) expression and fibroblast growth factor receptor 1 (FGFR1) amplification in stage III/IV lung squamous cell carcinoma (SQC). Thoracic Cancer 8:2, pages 73-79.
Crossref
Crossref
Guangzhi He, Chenhong Zheng, Huiping Huo, Huiming Zhang, Zhiquan Zhu, Junlai Li & Hongpeng Zhang. (2016) TACE combined with dendritic cells and cytokine-induced killer cells in the treatment of hepatocellular carcinoma: A meta-analysis. International Immunopharmacology 40, pages 436-442.
Crossref
Crossref
Joost Hegmans, Lysanne Lievense & Joachim Aerts. 2016. Cancer Genetics and Genomics for Personalized Medicine. Cancer Genetics and Genomics for Personalized Medicine
175
187
.
Haili Qian, Haijuan Wang, Xiuwen Guan, Zongbi Yi & Fei Ma. (2016) Adoptive immunotherapy combined chemoradiotherapy for non-small-cell lung cancer. Anti-Cancer Drugs 27:5, pages 433-438.
Crossref
Crossref
Lysanne Lievense, Joachim Aerts & Joost Hegmans. 2016. Lung Cancer and Personalized Medicine. Lung Cancer and Personalized Medicine
59
90
.
Xuebin Ma, Cong Ma, Wei Qiu, Hongxia Yuan, Ping Yang & Jinbo Kang. (2015) In vitro incubation of cytokine-induced killer cells from patients with and without hepatitis B virus and a cell subset analysis. Oncology and Translational Medicine 1:6, pages 275-279.
Crossref
Crossref
Jiabei He, Ying Hu, Mingming Hu & Baolan Li. (2015) Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer. Scientific Reports 5:1.
Crossref
Crossref
BIN CHEN, LIFEN LIU, HAIYAN XU, YIJIN YANG, LING ZHANG & FENGCHUN ZHANG. (2015) Effectiveness of immune therapy combined with chemotherapy on the immune function and recurrence rate of cervical cancer. Experimental and Therapeutic Medicine 9:3, pages 1063-1067.
Crossref
Crossref
JUN LI, ZHENHUA WANG, KAI MAO & XIXI GUO. (2014) Clinical significance of serum T helper 1/T helper 2 cytokine shift in patients with non-small cell lung cancer. Oncology Letters 8:4, pages 1682-1686.
Crossref
Crossref
Rui-xian Han, Xu Liu, Pan Pan, Ying-jie Jia & Jian-chun Yu. (2014) Effectiveness and Safety of Chemotherapy Combined with Dendritic Cells Co-Cultured with Cytokine-Induced Killer Cells in the Treatment of Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis. PLoS ONE 9:9, pages e108958.
Crossref
Crossref
Xiaosun Liu, Hailong Jin, Geer Zhang, Xianke Lin, Chao Chen, Jianyi Sun, Yu Zhang, Qing Zhang & Jiren Yu. (2014) Intratumor IL-17-Positive Mast Cells Are the Major Source of the IL-17 That Is Predictive of Survival in Gastric Cancer Patients. PLoS ONE 9:9, pages e106834.
Crossref
Crossref
Junying Wang & Xueju Wang. (2014) Beyond chemotherapy and targeted therapy: adoptive cellular therapy in non-small cell lung cancer. Molecular Biology Reports 41:9, pages 6317-6323.
Crossref
Crossref
Congguo Jin, Jia Li, Yeying Wang, Xiaoqun Chen, Yanhua Che, Xin Liu, Xicai Wang & Hutcha Sriplung. (2014) Impact of Cellular Immune Function on Prognosis of Lung Cancer Patients after Cytokine-induced Killer Cell Therapy. Asian Pacific Journal of Cancer Prevention 15:15, pages 6009-6014.
Crossref
Crossref
Lei Zhao, Wen-Jia Wang, Jin-Nan Zhang & Xing-Yi Zhang. (2014) 5-Fluorouracil and Interleukin-2 Immunochemotherapy Enhances Immunogenicity of Non-Small Cell Lung Cancer A549 Cells through Upregulation of NKG2D Ligands. Asian Pacific Journal of Cancer Prevention 15:9, pages 4039-4044.
Crossref
Crossref
MIN ZHAO, HONGBING LI, LEI LI & YIJIE ZHANG. (2014) Effects of a gemcitabine plus platinum regimen combined with a dendritic cell-cytokine induced killer immunotherapy on recurrence and survival rate of non-small cell lung cancer patients. Experimental and Therapeutic Medicine 7:5, pages 1403-1407.
Crossref
Crossref
Barbara Merelli, Daniela Massi, Laura Cattaneo & Mario Mandalà. (2014) Targeting the PD1/PD-L1 axis in melanoma: Biological rationale, clinical challenges and opportunities. Critical Reviews in Oncology/Hematology 89:1, pages 140-165.
Crossref
Crossref
Shujing Shi, Longbang Chen & Guichun Huang. (2013) Antiangiogenic therapy improves the antitumor effect of adoptive cell immunotherapy by normalizing tumor vasculature. Medical Oncology 30:4.
Crossref
Crossref
Yuqi Wang, Weimin Dai, Xiangyang Chu, Bo Yang, Ming Zhao & Yu’e Sun. (2013) Metformin inhibits lung cancer cells proliferation through repressing microRNA-222. Biotechnology Letters 35:12, pages 2013-2019.
Crossref
Crossref